Back to Search
DAVID KORNHAUSER, DO
DO
Family Medicine Physician
NPI: 1649202896Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
27697(WI)DR.0024705(CO)
Research & Publications (7)
Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.
PMID 19129749·Clin Pharmacol Ther·2009
2-rct
Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects.
PMID 19129748·Clin Pharmacol Ther·2009
2-rct
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist.
PMID 12850842·Platelets·2003
3-trial
Integrated pharmacokinetic/pharmacodynamic model of XV459, a potent and specific GPIIb/IIIa inhibitor, in healthy male volunteers.
PMID 12463727·J Clin Pharmacol·2002
3-trial
Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans.
PMID 12151999·Clin Pharmacol Ther·2002
3-trial
Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers.
PMID 12092741·J Clin Pharmacol·2002
3-trial
Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers.
PMID 11248285·Thromb Res·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2490 W 26TH AVE, STE A120
DENVER, CO 80211 - Phone
- (303) 925-4580
Quick Facts
- NPI
- 1649202896
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile